Continued strong growth in 2016. Company now has more than 150 patents and trademarks worldwide
Companies
U.S. Launch and First Commercial Use of Abbott’s New EnSite™ Precision Cardiac Mapping System
Enhanced system allows better 3D images of anatomical sources of irregular heartbeat
Adherium Appoints Digital Health Pioneer to Lead European Business Development
Digital health veteran to join expanding global team
DePuy Synthes ATTUNE® Knee: Aussie Data Supports UK Registry Findings
Latest Australian joint registry data confirm positive early results for the ATTUNE® Knee System
UK Joint Registry Data Confirms Positive Early Results for the DePuy Synthes ATTUNE® Knee System
Large hospital administrative database review also indicated ATTUNE Knee patients leave the hospital faster and are more likely to be discharged home sooner
Codman Neuro Expands Neurovascular Portfolio with Acquisition of Pulsar Vascular
PulseRider will complement Codman Neuro’s neurovascular portfolio of products for hemorrhagic and ischemic stroke.
Zimmer-Biomet Launches Personalized Shoulder Reconstruction System
First commercially available patient-matched Glenoid implant allows surgeons to address extensive bone loss and deformities
Medtronic Launches Outcome-Oriented Orthopedic Model
Medtronic Orthopedic Solutions targets drive clinical and economic outcomes in total joint replacement episodes of care
NASS Sees DePuy Synthes Spine Launches
SYNFIX® Evolution secured spacer system targets biomechanical stability with “efficient” instrumentation in degenerative disc disease procedures
New CEO for CLI Innovator LimFlow SA
Past officer at TAVI developer Direct Flow Medical, Daniel Rose will now head up LimFlow with its innovative Critical Limb Ischemia offering
New EU-Based MedTech Accelerator Kicks off with $11.5m
MD Start II follows its successful predecessor by offering incubation and management for start-ups
Approval, Clinical Use, Funding: Fortimedix Surgical Raises €11M for Commercial Launch
FMX314 received both CE Mark Approval and U.S. FDA 510(k) clearance last quarter
FDA Approves St. Jude Medical BurstDR™ Spinal Cord Stimulation for Chronic Pain
BurstDR stimulation targets chronic pain patients with a new therapy option designed to provide less pain, less suffering and less therapy maintenance
Zimmer Biomet to Acquire Clinical Graphics to Aid Surgical Decision Making
Zimmer Biomet adds 3D Range-of-Motion Simulation capability
St. Jude’s LAA Occlusion Device IDE Trial Begins
The AMPLATZER™ Amulet™ IDE trial aims to deliver data that will support FDA approval of the device, increasing treatment options for U.S. AF patients at risk of stroke
St. Jude’s Newly Launched SyncAV CRT Technology Targets Non-Responsive CRT Patients
SyncAV™ CRT technology provides further advantages to support physicians seeking new treatment options for heart failure patients